Abstract
Introduction: Among different 2-D nanostructures, molybdenum disulfide (MoS2) has shown great potential as a good candidate in drug delivery systems. However, their biocompatibility and water dispersibility are the main issues for these purposes. With the aim of improving the MoS2 dispersibility, a novel drug delivery system based on polymer-modified MoS2 nanosheets was successfully prepared and characterized.
Methods: In this study, MoS2 nanosheets were prepared using a simple oleum treatment exfoliation approach and then modified by grafting thermos-responsive polymer N- isopropylacrylamide (NIPAM) and polyethylene glycol (PEG). The structural and morphological properties of the MoS2/NIPAM/ PEG nanosheets were characterized via Scanning Electron Microscopy (SEM), X-Ray Diffraction (XRD), Fourier- Transform Infrared Spectroscopy (FTIR), and Thermogravimetric analysis (TGA/DSC). Initially, the adsorption behavior of the grafted nanoadsorbent was assessed for sorption of doxorubicin as an anticancer drug model. The influence of various parameters such as pH, temperature, and contact time was evaluated. Different kinetic and isotherm models were employed to investigate the (DOX) adsorption mechanism.
Results: The obtained results revealed that the DOX adsorption onto the MoS2/NIPAM/ PEG followed the Langmuir isotherm and pseudo-second-order models. In the next step, polymer grafted MoS2 nanosheets were used as thermos-sensitive drug nanocarriers for near-infrared (NIR) photothermal therapy. The combination of chemotherapy and photothermal therapy was also investigated, which indicated a remarkable improvement of cell apoptotic rate compared to monotherapy. Also, MTT assays showed that the MoS2/NIPAM/ PEG had high biocompatibility.
Conclusion: The novel thermo-responsive MoS2/NIPAM/ PEG showed great potential for targeted and controlled drug delivery.
Keywords: Molybdenum disulfide, N-isopropylacrylamide, cytotoxicity, doxorubicin, photothermal therapy, monotherapy.
Current Drug Delivery
Title:NIPAM/PEG/ MoS2 Nanosheets for Dual Triggered Doxorubicin Release and Combined Chemo-photothermal Cancer Therapy
Volume: 18 Issue: 9
Author(s): Elham Reza Soltani, Kambiz Tahvildari*, Elham Moniri and Homayoun Ahmad Panahi
Affiliation:
- Department of Chemistry, North Tehran Branch, Islamic Azad University, Tehran,Iran
Keywords: Molybdenum disulfide, N-isopropylacrylamide, cytotoxicity, doxorubicin, photothermal therapy, monotherapy.
Abstract:
Introduction: Among different 2-D nanostructures, molybdenum disulfide (MoS2) has shown great potential as a good candidate in drug delivery systems. However, their biocompatibility and water dispersibility are the main issues for these purposes. With the aim of improving the MoS2 dispersibility, a novel drug delivery system based on polymer-modified MoS2 nanosheets was successfully prepared and characterized.
Methods: In this study, MoS2 nanosheets were prepared using a simple oleum treatment exfoliation approach and then modified by grafting thermos-responsive polymer N- isopropylacrylamide (NIPAM) and polyethylene glycol (PEG). The structural and morphological properties of the MoS2/NIPAM/ PEG nanosheets were characterized via Scanning Electron Microscopy (SEM), X-Ray Diffraction (XRD), Fourier- Transform Infrared Spectroscopy (FTIR), and Thermogravimetric analysis (TGA/DSC). Initially, the adsorption behavior of the grafted nanoadsorbent was assessed for sorption of doxorubicin as an anticancer drug model. The influence of various parameters such as pH, temperature, and contact time was evaluated. Different kinetic and isotherm models were employed to investigate the (DOX) adsorption mechanism.
Results: The obtained results revealed that the DOX adsorption onto the MoS2/NIPAM/ PEG followed the Langmuir isotherm and pseudo-second-order models. In the next step, polymer grafted MoS2 nanosheets were used as thermos-sensitive drug nanocarriers for near-infrared (NIR) photothermal therapy. The combination of chemotherapy and photothermal therapy was also investigated, which indicated a remarkable improvement of cell apoptotic rate compared to monotherapy. Also, MTT assays showed that the MoS2/NIPAM/ PEG had high biocompatibility.
Conclusion: The novel thermo-responsive MoS2/NIPAM/ PEG showed great potential for targeted and controlled drug delivery.
Export Options
About this article
Cite this article as:
Soltani Reza Elham, Tahvildari Kambiz *, Moniri Elham and Panahi Ahmad Homayoun , NIPAM/PEG/ MoS2 Nanosheets for Dual Triggered Doxorubicin Release and Combined Chemo-photothermal Cancer Therapy, Current Drug Delivery 2021; 18 (9) . https://dx.doi.org/10.2174/1567201818666210217160759
DOI https://dx.doi.org/10.2174/1567201818666210217160759 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advancements in Robotic and AI-Based Drug Discovery and Delivery for Neurological Disorders
Neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and brain tumors, pose significant challenges in drug delivery due to the blood-brain barrier's intricate structure and the complexity of neuronal networks. Traditional drug delivery methods often fall short in reaching therapeutic concentrations within the central nervous system, limiting treatment efficacy and ...read more
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access to both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structure-based Virtual Screening for the Identification of High-affinity Small Molecule Towards STAT3 for the Clinical Treatment of Osteosarcoma
Current Topics in Medicinal Chemistry The Therapeutic Potential of the Wnt Signaling Pathway in Bone Disorders
Current Molecular Pharmacology Novel Orphan Nuclear Receptors-Coregulator Interactions Controlling Anti-Cancer Drug Metabolism
Current Drug Metabolism A Systematic Review of Selected Musculoskeletal Late Effects in Survivors of Childhood Cancer
Current Pediatric Reviews Review of Noscapine and its Analogues as Potential Anti-Cancer Drugs
Mini-Reviews in Organic Chemistry Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy
Clinical Cancer Drugs The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets Diagnostic, Prognostic and Therapeutic Potential of Heat Shock Proteins in Schistosomiasis and Bladder Cancer: A Review
Letters in Drug Design & Discovery C-20 Cyclopropyl Vitamin D3 Analogs
Current Topics in Medicinal Chemistry Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection
Cardiovascular & Hematological Disorders-Drug Targets Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Targeting Anti-Cancer Agents and Cancer Treatments)
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs (miRNAs) in Colorectal Cancer: From Aberrant Expression Towards Therapy
Current Pharmaceutical Design Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer
Recent Patents on Anti-Cancer Drug Discovery Chemosensitization by Antisense Oligonucleotides Targeting MDM2
Current Cancer Drug Targets NOTCH Signaling as a Novel Cancer Therapeutic Target
Current Cancer Drug Targets Implementing Cancer Exercise Rehabilitation: An Update on Recommendations for Clinical Practice
Current Cancer Therapy Reviews FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer
Current Cancer Drug Targets Methods for Identifying Cardiovascular Agents: A Review
Recent Patents on Cardiovascular Drug Discovery Bioengineered 3D Scaffolds in Cancer Research: Focus on Epithelial to Mesenchymal Transition and Drug Screening
Current Pharmaceutical Design